Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 182 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 3621

Topic: Biology, Genetics & Bone Healing

The direct insertion of a tendon or ligament into bone occurs through a highly specialized transition zone designed to minimize stress concentrations. What is the correct anatomical order of these four zones from tendon to bone?

. Tendon, uncalcified fibrocartilage, calcified fibrocartilage, bone
. Tendon, hyaline cartilage, uncalcified fibrocartilage, bone
. Tendon, woven bone, lamellar bone, cortical bone
. Tendon, calcified fibrocartilage, uncalcified fibrocartilage, bone
. Tendon, Sharpey's fibers, periosteum, bone

Correct Answer & Explanation

. Tendon, uncalcified fibrocartilage, calcified fibrocartilage, bone

Explanation

A direct (enthesis) insertion transitions through four distinct layers: tendon, uncalcified fibrocartilage, calcified fibrocartilage, and bone. The tidemark separates the uncalcified and calcified fibrocartilage zones.

Question 3622

Topic: Biology, Genetics & Bone Healing

Bone homeostasis is maintained by the balanced activity of osteoblasts and osteoclasts. From which specific cellular lineage do osteoclasts originate?

. Mesenchymal stem cell lineage
. Hematopoietic stem cell (macrophage/monocyte) lineage
. Neural crest progenitor cells
. Endodermal stem cell lineage
. Fibroblastic lineage

Correct Answer & Explanation

. Hematopoietic stem cell (macrophage/monocyte) lineage

Explanation

Osteoclasts are multinucleated giant cells that originate from hematopoietic stem cells, specifically the monocyte-macrophage lineage. Osteoblasts, on the other hand, are derived from local mesenchymal stem cells.

Question 3623

Topic: Biology, Genetics & Bone Healing

Recent advances in osteoporosis treatment include the use of romosozumab. Which of the following best describes the molecular target of this monoclonal antibody?

. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Parathyroid hormone receptor type 1 (PTH1R)
. Sclerostin, thereby disinhibiting the Wnt/beta-catenin signaling pathway
. Cathepsin K, preventing osteoclast-mediated bone resorption
. Fibroblast growth factor 23 (FGF23)

Correct Answer & Explanation

. Sclerostin, thereby disinhibiting the Wnt/beta-catenin signaling pathway

Explanation

Romosozumab is a humanized monoclonal antibody that targets and binds to sclerostin. Sclerostin, produced by osteocytes, normally inhibits the Wnt/beta-catenin pathway, which is crucial for osteoblast-mediated bone formation. By blocking sclerostin, romosozumab exerts a dual effect: increasing bone formation and decreasing bone resorption.

Question 3624

Topic: Biology, Genetics & Bone Healing

A 35-year-old female undergoes curettage and cementing of a giant cell tumor (GCT) of the distal femur. Six months later, she presents with local recurrence. The multidisciplinary tumor board recommends medical therapy before revision surgery. Which mechanism of action represents the first-line biologic agent for this condition?

. Inhibition of the mTOR pathway
. Inhibition of the tyrosine kinase domain of vascular endothelial growth factor (VEGF)
. Inhibition of the RANK ligand (RANKL) to prevent osteoclast-like giant cell formation
. Direct alkylation of DNA in rapidly dividing neoplastic cells
. Stimulation of osteoblast apoptosis via bisphosphonate accumulation

Correct Answer & Explanation

. Inhibition of the RANK ligand (RANKL) to prevent osteoclast-like giant cell formation

Explanation

Giant cell tumor of bone (GCTB) features neoplastic mononuclear stromal cells that express high levels of RANKL, driving the formation of destructive osteoclast-like giant cells. Denosumab, a monoclonal antibody against RANKL, is an effective medical treatment for recurrent, unresectable, or metastatic GCTB.

Question 3625

Topic: Biology, Genetics & Bone Healing

Which of the following bone graft options strictly provides osteoconduction, osteoinduction, and osteogenesis?

. Demineralized bone matrix (DBM)
. Cancellous allograft
. Cortical allograft
. Autogenous iliac crest bone graft (ICBG)
. Recombinant human bone morphogenetic protein-2 (rhBMP-2) on a collagen sponge

Correct Answer & Explanation

. Autogenous iliac crest bone graft (ICBG)

Explanation

Autograft, such as an iliac crest bone graft (ICBG), is the 'gold standard' because it is the only graft type that possesses all three properties: osteoconduction (scaffold), osteoinduction (growth factors like BMPs), and osteogenesis (living osteoprogenitor cells and osteoblasts). Allografts lack osteogenesis, and DBM lacks osteogenesis and meaningful structural osteoconduction.

Question 3626

Topic: Biology, Genetics & Bone Healing

A 68-year-old man presents with increasing hat size, bowing of the tibiae, and hearing loss. Radiographs show mixed lytic and sclerotic lesions. Which of the following serum parameters is most likely to be isolated and significantly elevated?

. Calcium
. Phosphorus
. Parathyroid hormone (PTH)
. Alkaline phosphatase (ALP)
. 25-hydroxyvitamin D

Correct Answer & Explanation

. Alkaline phosphatase (ALP)

Explanation

The clinical presentation is classic for Paget's disease of bone. This condition is characterized by massive bone turnover resulting in highly elevated serum alkaline phosphatase, while calcium and phosphorus typically remain normal.

Question 3627

Topic: Biology, Genetics & Bone Healing

Which of the following correctly describes the cellular mechanism of action of nitrogen-containing bisphosphonates such as alendronate?

. Inhibition of RANKL binding to the RANK receptor
. Inhibition of farnesyl pyrophosphate synthase in the mevalonate pathway
. Direct stimulation of osteoblast Wnt/beta-catenin signaling
. Action as a decoy receptor for osteoprotegerin
. Direct inhibition of cathepsin K

Correct Answer & Explanation

. Inhibition of farnesyl pyrophosphate synthase in the mevalonate pathway

Explanation

Nitrogen-containing bisphosphonates are internalized by osteoclasts and inhibit farnesyl pyrophosphate synthase within the mevalonate pathway. This prevents protein prenylation, disrupting osteoclast function and promoting early apoptosis.

Question 3628

Topic: Biology, Genetics & Bone Healing

When a diaphyseal fracture is fixed with a rigid dynamic compression plate (DCP) resulting in absolute stability and less than 2% interfragmentary strain, which specific process of bone healing predominates?

. Endochondral ossification
. Intramembranous ossification alone
. Primary bone healing via Haversian remodeling
. Secondary bone healing with intermediate callus
. Chondrogenesis and subsequent apoptosis

Correct Answer & Explanation

. Primary bone healing via Haversian remodeling

Explanation

Absolute fracture stability with minimal interfragmentary strain suppresses callus formation. Healing occurs via primary bone healing, wherein osteoclasts form cutting cones that cross the fracture line, followed immediately by osteoblasts laying down new lamellar bone (Haversian remodeling).

Question 3629

Topic: Biology, Genetics & Bone Healing

A surgeon applies a long, locked bridging plate to a highly comminuted midshaft femur fracture, leaving the fracture site undisturbed. This specific fixation construct relies on which biomechanical principle to promote healing?

. Absolute stability allowing primary bone healing via cutting cones
. Relative stability allowing controlled micromotion to stimulate secondary bone healing
. Rigid fixation promoting direct intramembranous ossification
. Dynamic axial compression to eliminate interfragmentary strain
. Distraction osteogenesis via the Ilizarov method

Correct Answer & Explanation

. Relative stability allowing controlled micromotion to stimulate secondary bone healing

Explanation

A bridging plate intentionally bypasses the zone of comminution, preserving fracture hematoma biology while providing relative stability. This construct allows for controlled interfragmentary strain (typically 2% to 10%), which robustly stimulates secondary bone healing via callus formation.

Question 3630

Topic: Biology, Genetics & Bone Healing

Denosumab is an antiresorptive medication used for treating severe osteoporosis. What is its specific molecular mechanism of action?

. Agonist of the Wnt/beta-catenin signaling pathway
. Monoclonal antibody targeting and neutralizing sclerostin
. Synthetic analogue of parathyroid hormone (PTH 1-34)
. Monoclonal antibody that binds to and inhibits RANK ligand (RANKL)
. Selective estrogen receptor modulator (SERM)

Correct Answer & Explanation

. Monoclonal antibody that binds to and inhibits RANK ligand (RANKL)

Explanation

Denosumab is a fully human monoclonal antibody that directly binds to RANKL, mimicking the body's natural decoy receptor, osteoprotegerin (OPG). By blocking RANKL from binding to the RANK receptor on osteoclasts, it effectively halts osteoclast maturation, function, and survival.

Question 3631

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) induce osteogenesis by signaling through transmembrane receptors. Which intracellular signaling pathway is primarily activated by BMPs to promote osteoblast differentiation?

. Wnt/beta-catenin pathway
. JAK/STAT pathway
. Smad 1/5/8 pathway
. MAPK/ERK pathway
. Notch signaling pathway

Correct Answer & Explanation

. Smad 1/5/8 pathway

Explanation

BMPs bind to serine/threonine kinase receptors on the cell membrane, triggering the phosphorylation of intracellular Smad proteins (Smad 1, 5, and 8). These activated Smads form a complex with Smad 4 and translocate to the nucleus to initiate transcription of osteogenic genes.

Question 3632

Topic: Biology, Genetics & Bone Healing

Teriparatide is an anabolic pharmacological agent utilized in the treatment of severe osteoporosis. What is its specific mechanism of action and the maximum FDA-approved duration for continuous lifetime use?

. Inhibits osteoclast resorption; 5 years
. Recombinant human parathyroid hormone (PTH 1-34) stimulating osteoblasts; 2 years
. Monoclonal antibody against RANKL; 3 years
. Selective estrogen receptor modulator; 10 years
. Sclerostin inhibitor; 1 year

Correct Answer & Explanation

. Recombinant human parathyroid hormone (PTH 1-34) stimulating osteoblasts; 2 years

Explanation

Teriparatide is a recombinant parathyroid hormone analog (PTH 1-34) that has a potent anabolic effect on bone by stimulating osteoblast activity when given intermittently. Its maximum FDA-approved lifetime use is restricted to 2 years due to a theoretical risk of osteosarcoma observed in animal models.

Question 3633

Topic: Biology, Genetics & Bone Healing

Denosumab is utilized as an adjuvant or neoadjuvant treatment for advanced Giant Cell Tumor of Bone (GCTB). At the cellular level, denosumab exerts its therapeutic effect by directly targeting and binding to which entity within the tumor microenvironment?

. RANK receptor on the multinucleated giant cells
. RANKL produced by the neoplastic mononuclear stromal cells
. Osteoprotegerin (OPG) produced by osteoblasts
. Vascular Endothelial Growth Factor (VEGF) in the tumor matrix
. The tartrate-resistant acid phosphatase (TRAP) enzyme

Correct Answer & Explanation

. RANKL produced by the neoplastic mononuclear stromal cells

Explanation

In Giant Cell Tumor of Bone, the mononuclear stromal cells are the actual neoplastic elements that oversecrete RANKL. Denosumab, a monoclonal antibody, binds directly to this RANKL, preventing it from activating the non-neoplastic, bone-resorbing multinucleated giant cells.

Question 3634

Topic: Biology, Genetics & Bone Healing

During distraction osteogenesis using an Ilizarov frame, bone healing occurs primarily through which of the following processes?

. Endochondral ossification
. Intramembranous ossification
. Creeping substitution
. Appositional bone growth
. Cutting cone remodeling

Correct Answer & Explanation

. Intramembranous ossification

Explanation

Distraction osteogenesis promotes new bone formation primarily via intramembranous ossification, bypassing the cartilaginous intermediate phase. This occurs under conditions of stable fixation and controlled, gradual mechanical tension.

Question 3635

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory, secondary bone healing (callus formation) optimally occurs within which of the following ranges of mechanical strain at the fracture site?

. Less than 2%
. 2% to 10%
. 10% to 30%
. 30% to 50%
. Greater than 50%

Correct Answer & Explanation

. 2% to 10%

Explanation

According to Perren's strain theory, primary bone healing occurs when strain is less than 2%. Secondary bone healing (which includes endochondral ossification and callus formation) occurs in the presence of moderate strain, typically between 2% and 10%. Granulation tissue can tolerate up to 100% strain, cartilage up to 10%, and lamellar bone only 2%.

Question 3636

Topic: Biology, Genetics & Bone Healing

Nitrogen-containing bisphosphonates (e.g., alendronate, zoledronic acid) decrease osteoclastic bone resorption by inhibiting which of the following enzymes in the mevalonate pathway?

. Cathepsin K
. HMG-CoA reductase
. Farnesyl pyrophosphate (FPP) synthase
. Carbonic anhydrase II
. Tartrate-resistant acid phosphatase (TRAP)

Correct Answer & Explanation

. Farnesyl pyrophosphate (FPP) synthase

Explanation

Nitrogen-containing bisphosphonates inhibit farnesyl pyrophosphate (FPP) synthase in the mevalonate pathway. This prevents the prenylation of small GTPase proteins (like Rab, Rho, Rac) essential for osteoclast function, ruffled border formation, and cell survival, eventually leading to osteoclast apoptosis.

Question 3637

Topic: Biology, Genetics & Bone Healing

Denosumab is an antiresorptive medication used in the treatment of osteoporosis. What is its exact mechanism of action?

. Binds directly to the RANK receptor on osteoclasts
. Binds to RANKL, preventing its interaction with RANK
. Stimulates osteoprotegerin (OPG) production by osteoblasts
. Inhibits the Wnt/beta-catenin signaling pathway
. Directly stimulates osteoblast differentiation via PTH1R

Correct Answer & Explanation

. Binds to RANKL, preventing its interaction with RANK

Explanation

Denosumab is a fully human monoclonal antibody that binds to Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding to RANKL, it prevents RANKL from binding to the RANK receptor on osteoclast precursors and mature osteoclasts, thus inhibiting their differentiation, activation, and survival.

Question 3638

Topic: Biology, Genetics & Bone Healing

During secondary bone remodeling, a 'cutting cone' travels through cortical bone. Which of the following accurately describes the spatial arrangement of cells within this basic multicellular unit (BMU)?

. Osteoblasts are at the leading edge, followed by osteocytes
. Osteoclasts are at the leading edge, followed by a reversal zone and trailing osteoblasts
. Chondrocytes are at the leading edge, followed by osteoblasts
. Macrophages are at the leading edge, directly followed by osteoclasts
. Osteoblasts and osteoclasts act simultaneously at the exact same geographic leading edge

Correct Answer & Explanation

. Osteoclasts are at the leading edge, followed by a reversal zone and trailing osteoblasts

Explanation

In cortical bone remodeling, the basic multicellular unit (BMU) forms a 'cutting cone'. Osteoclasts are situated at the leading edge (the head of the cone) to resorb bone. They are followed by a reversal zone containing mononuclear cells, and then trailing osteoblasts that lay down new osteoid (the closing cone).

Question 3639

Topic: Biology, Genetics & Bone Healing

Parathyroid hormone (PTH) plays a critical role in calcium homeostasis and bone remodeling. Through which primary cellular mechanism does PTH stimulate osteoclast activity?

. Binding directly to PTH receptors on the osteoclast cell membrane
. Binding to PTH1R on osteoblasts, which upregulates RANKL expression
. Inhibiting the release of macrophage colony-stimulating factor (M-CSF)
. Stimulating calcitonin release from the thyroid gland
. Directly increasing intestinal calcium absorption independent of Vitamin D

Correct Answer & Explanation

. Binding to PTH1R on osteoblasts, which upregulates RANKL expression

Explanation

Osteoclasts do not possess receptors for Parathyroid Hormone (PTH). PTH binds to the PTH1R receptor on osteoblasts and osteocytes, which then increases their expression of RANKL and decreases OPG production. The increased RANKL binds to RANK on osteoclast precursors, stimulating osteoclastogenesis and bone resorption.

Question 3640

Topic: Biology, Genetics & Bone Healing

Which of the following bone graft substitutes inherently possesses osteoinductive properties but definitively lacks both osteoconductive and osteogenic properties?

. Cancellous autograft
. Demineralized bone matrix (DBM)
. Calcium phosphate cement
. Fresh frozen structural allograft
. Corticocancellous autograft

Correct Answer & Explanation

. Demineralized bone matrix (DBM)

Explanation

Demineralized bone matrix (DBM) is osteoinductive due to the release and preservation of bone morphogenetic proteins (BMPs) during the acid demineralization process. However, the process removes structural rigidity (lacking true osteoconduction) and devitalizes all cells (lacking osteogenesis).

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page